Bristol Myers turns to Oxford Biomedica for CAR-T manufacturing
Oxford Biomedica set to receive up to $96m to support the development of Juno’s CAR-T therapies.
Archives for March 20, 2020
CGTC in ‘third phase’ expansion of cell and gene manufacturing site
CGTC will add seven laboratories to its manufacture site in the UK, with most of the work taking place off-site.
Univercells spins out viral vector CDMO to meet capacity demands
Univercells announces the launch of Exothera, a CDMO focusing on viral vectors to support cell and gene therapy developers.